Expression of genes encoding IGFBPs, SNARK, CD36, and PECAM1 in the liver of mice treated with chromium disilicide and titanium nitride nanoparticles

Alarifi S, Ali D, Alkahtani S. Mechanistic investigation of toxicity of chromium oxide nanoparticles in murine fi brosarcoma cells. Int J Nanomedicine 11, 1253-1259, 2016.10.2147/IJN.S99995482023327099490Search in Google Scholar

Avci NG, Fan Y, Dragomir A, Akay YM, Akay M. Investigating the infl uence of HUVECs in the formation of glioblastoma spheroids in high-throughput three-dimensional microwells. IEEE Trans Nanobioscience 14, 790-796, 2015.10.1109/TNB.2015.247781826571536Search in Google Scholar

Azar WJ, Azar SH, Higgins S, Hu JF, Hoffman AR, Newgreen DF, Werther GA, Russo VC. IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells. Endocrinology 12, 3332-3342, 2011.10.1210/en.2011-112121750048Search in Google Scholar

Bach LA. Insulin-like growth factor binding proteins--an update. Pediatr Endocrinol Rev 13, 521-530, 2015.Search in Google Scholar

Baxter RC. Nuclear actions of insulin-like growth factor binding protein-3. Gene 569, 7-13, 201510.1016/j.gene.2015.06.028449626926074086Search in Google Scholar

Bochkov VN, Philippova M, Oskolkova O, Kadl A, Furnkranz A, Karabeg E, Breuss J, Minchenko OH, Mechtcheriakova D, Hohensinner P, Rychli K, Wojta J, Resink T, Binder BR, Leitinger N. Oxidized phospholipids stimulate angiogenesis via induction of VEGF, IL-8, COX-2 and ADAMTS-1 metalloprotease, implicating a novel role for lipid oxidation in progression and destabilization of atherosclerotic lesions. Circ Res 99, 900-908, 2006.10.1161/01.RES.0000245485.04489.ee16973904Search in Google Scholar

Bravo R, Parra V, Gatica D, Rodriguez AE, Torrealba N, Paredes F, Wang ZV, Zorzano A, Hill JA, Jaimovich E, Quest AF, Lavandero S. Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. Int Rev Cell Mol Biol 301, 215-290, 2013.10.1016/B978-0-12-407704-1.00005-1366655723317820Search in Google Scholar

Chevet E, Hetz C, Samali A. Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis. Cancer Discov 5, 586-597, 2015.10.1158/2159-8290.CD-14-149025977222Search in Google Scholar

Chu JP, Yu CC, Tanatsugu Y, Yasuzawa M, Shen YL. Non-stick syringe needles: Benefi cial eff ects of thin fi lm metallic glass coating. Sci Rep 6, 31847, 2016.10.1038/srep31847500415727573062Search in Google Scholar

Contois LW, Akalu A, Caron JM, Tweedie E, Cretu A, Henderson T, Liaw L, Friesel R, Vary C, Brooks PC. Inhibition of tumor-associated αvβ3 integrin regulates the angiogenic switch by enhancing expression of IGFBP-4 leading to reduced melanoma growth and angiogenesis in vivo. Angiogenesis 18, 31-46, 2015.10.1007/s10456-014-9445-2428151225249331Search in Google Scholar

Dejeans N, Barroso K, Fernandez-Zapico ME, Samali A, Chevet E. Novel roles of the unfolded protein response in the control of tumor development and aggressiveness. Semin Cancer Biol 33, 67-73, 2015.10.1016/j.semcancer.2015.04.00725953433Search in Google Scholar

Ding M, Bruick RK, Yu Y. Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling. Nat Cell Biol 18, 319-327, 2016.10.1038/ncb3311500150126854565Search in Google Scholar

Fu TG, Wang L, Li W, Li JZ, Li J. miR-143 inhibits oncogenic traits by degrading NUAK2 in glioblastoma. Int J Mol Med 37, 1627-1635, 2016.10.3892/ijmm.2016.256227081712Search in Google Scholar

Gokulakrishnan K, Velmurugan K, Ganesan S, Mohan V: Circulating levels of insulin-like growth factor binding protein-1 in relation to insulin resistance, type 2 diabetes mellitus, and metabolic syndrome (Chennai Urban Rural Epidemiology Study 118). Metab Clin Exp 61, 43-46, 2012.10.1016/j.metabol.2011.05.01421741060Search in Google Scholar

Guaita-Esteruelas S, Bosquet A, Saavedra P, Guma J, Girona J, Lam EW, Amillano K, Borras J, Masana L. Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins. Mol Carcinog 56, 208-217, 2017.10.1002/mc.2248527061264Search in Google Scholar

Han J, Back SH, Hur J, Lin YH, Gildersleeve R, Shan J, Yuan CL, Krokowski D, Wang S, Hatzoglou M, Kilberg MS, Sartor MA, Kaufman RJ. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat Cell Biol 15, 481-490, 2013.10.1038/ncb2738369227023624402Search in Google Scholar

Han S, Li Z, Master LM, Master ZW, Wu A. Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway. Br J Cancer 111, 1400-1409, 2014.10.1038/bjc.2014.435418385625093489Search in Google Scholar

Hellewell AL, Adams JC. Insider trading: Extracellular matrix proteins and their non-canonical intracellular roles. Bioessays 38, 77-88, 2016.10.1002/bies.20150010326735930Search in Google Scholar

Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner. Cell Signal 25, 1395-1402, 2013.10.1016/j.cellsig.2013.02.01823499909Search in Google Scholar

Hsu HF, Tsai PC, Lu KC. Single-crystalline chromium silicide nanowires and their physical properties. Nanoscale Res Lett 10, 50, 2015.10.1186/s11671-015-0776-8438512025852347Search in Google Scholar

Humphries B, Wang Z, Yang C. Th e role of microRNAs in metal carcinogen-induced cell malignant transformation and tumorigenesis. Food Chem Toxicol 98(Pt A), 58-65, 2016.10.1016/j.fct.2016.02.012499246826903202Search in Google Scholar

Hwang JR, Cho YJ, Lee Y, Park Y, Han HD, Ahn HJ, Lee JH, Lee JW. Th e C-terminus of IGFBP-5 suppresses tumor growth by inhibiting angiogenesis. Sci Rep 6, 39334, 2016.10.1038/srep39334518024528008951Search in Google Scholar

Ilhan-Mutlu A, Siehs C, Berghoff AS, Ricken G, Widhalm G, Wagner L, Preusser M. Expression profi ling of angiogenesis- related genes in brain metastases of lung cancer and melanoma. Tumour Biol 37, 1173-1182, 2016.10.1007/s13277-015-3790-726277786Search in Google Scholar

Ingermann AR, Yang YF, Han J, Mikami A, Garza AE, Mohanraj L, Fan L, Idowu M, Ware JL, Kim HS, Lee DY, Oh Y. Identifi cation of a novel cell death receptor mediating IGFBP-3-induced anti-tumor eff ects in breast and prostate cancer. J Biol Chem 285, 30233-30246, 2010.10.1074/jbc.M110.122226294327820353938Search in Google Scholar

Johnson MA, Firth SM. IGFBP-3: a cell fate pivot in cancer and disease. Growth Horm IGF Res 24, 164-173, 2014.10.1016/j.ghir.2014.04.00724953254Search in Google Scholar

Karjalainen PP, Nammas W. Titanium-nitride-oxide-coated coronary stents: insights from the available evidence. Ann Med 2016.10.1080/07853890.2016.124435327690662Search in Google Scholar

Kim MS, Lee DY. Insulin-like growth factor (IGF)-I and IGF binding proteins axis in diabetes mellitus. Ann Pediatr Endocrinol Metab 20, 69-73, 2015.10.6065/apem.2015.20.2.69450499226191509Search in Google Scholar

Kim JC, Ha YJ, Tak KH, Roh SA, Kim CW, Kim TW, Kim SK, Kim SY, Cho DH, Kim YS. Complex behavior of ALDH1A1 and IGFBP1 in liver metastasis from a colorectal cancer. PLoS One 11, e0155160, 2016.10.1371/journal.pone.0155160485955927152521Search in Google Scholar

Liu C, Wu J, Zou MH. Activation of AMP-activated protein kinase alleviates high-glucose-induced dysfunction of brain microvascular endothelial cell tight-junction dynamics. Free Radic Biol Med 53, 1213-1221, 2012.10.1016/j.freeradbiomed.2012.07.003343701422796592Search in Google Scholar

Manie SN, Lebeau J, Chevet E. Cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. 3. Orchestrating the unfolded protein response in oncogenesis: an update. Am J Physiol Cell Physiol 307, C901-C907, 2014.10.1152/ajpcell.00292.201425186011Search in Google Scholar

Maurel M, McGrath EP, Mnich K, Healy S, Chevet E, Samali A. Controlling the unfolded protein response-mediated life and death decisions in cancer. Semin Cancer Biol 33, 57-66, 2015.10.1016/j.semcancer.2015.03.00325814342Search in Google Scholar

Miller HC, Frampton AE, Malczewska A, Ottaviani S, Stronach EA, Flora R, Kaemmerer D, Schwach G, Pfragner R, Faiz O, Kos-Kudła B, Hanna GB, Stebbing J, Castellano L, Frilling A. MicroRNAs associated with small bowel neuroendocrine tumours and their metastases. Endocr Relat Cancer 23, 711-726, 2016.10.1530/ERC-16-004427353039Search in Google Scholar

Minchenko DO, Minchenko OH. SNF1/AMP-activated protein kinases: genes, expression and biological role. In: Protein Kinases. Book 1, Dr. Gabriela Da Silva Xavier (Ed.). InTech 41-62, 2012.Search in Google Scholar

Minchenko DO, Prylutska SV, Moenner M, Minchenko OH, Prylutskyy YuI, Schutze C, Ritter U. Eff ect of C60 fullerene on the expression of ERN1 signaling related genes in human astrocytes. Mat-wiss u Werkstofft ech 44, 150-155, 2013a.10.1002/mawe.201300084Search in Google Scholar

Minchenko DO, Spivak MY, Herasymenko RM, Ivanov VK, Tretyakov YD, Minchenko OH. Eff ect of cerium dioxide nanoparticles on the expression of selected growth and transcription factors in human astrocytes. Mat-wiss u Werkstofft ech 44, 156-160, 2013b.10.1002/mawe.201300091Search in Google Scholar

Minchenko DO, Kharkova AP, Karbovskyi LL, Minchenko OH. Expression of insulin-like growth factor binding protein genes and its hypoxic regulation in U87 glioma cells depends on ERN1 mediated signaling pathway of endoplasmic reticulum stress. Endocr Regul 49, 73-83, 2015.10.4149/endo_2015_02_7325960008Search in Google Scholar

Minchenko DO, Kharkova AP, Tsymbal DO, Karbovskyi LL, Minchenko OH. Eff ect of hypoxia on the expression of genes encoding insulin-like growth factors and some related proteins in U87 glioma cells without IRE1 function. Endocr Regul 50, 43-54, 2016.10.1515/enr-2016-000827560636Search in Google Scholar

Musumeci G, Castorina A, Magro G, Cardile V, Castorina S, Ribatti D. Enhanced expression of CD31/platelet endothelial cell adhesion molecule 1 (PECAM1) correlates with hypoxia inducible factor-1 alpha (HIF-1α) in human glioblastoma multiforme. Exp Cell Res 339, 407-416, 2015.10.1016/j.yexcr.2015.09.00726376118Search in Google Scholar

Namiki T, Tanemura A, Valencia JC, Coelho SG, Passeron T, Kawaguchi M, Vieira WD, Ishikawa M, Nishijima W, Izumo T, Kaneko Y, Katayama I, Yamaguchi Y, Yin L, Polley EC, Liu H, Kawakami Y, Eishi Y, Takahashi E, Yokozeki H, Hearing VJ. AMP kinase-related kinase NUAK2 aff ects tumor growth, migration, and clinical outcome of human melanoma. Proc Natl Acad Sci USA 108, 6597-6602, 2011.10.1073/pnas.1007694108308101921460252Search in Google Scholar

Nijaguna MB, Patil V, Urbach S, Shwetha SD, Sravani K, Hegde AS, Chandramouli BA, Arivazhagan A, Marin P, Santosh V, Somasundaram K. Glioblastoma-derived macrophage colony-stimulating factor (MCSF) induces microglial release of insulin-like growth factor-binding protein 1 (IGFBP1) to promote angiogenesis. J Biol Chem 290, 23401-23415, 2015.10.1074/jbc.M115.664037464561026245897Search in Google Scholar

Ord T, Ord D, Adler P, Vilo J, Ord T. TRIB3 enhances cell viability during glucose deprivation in HEK293-derived cells by upregulating IGFBP2, a novel nutrient defi ciency survival factor. Biochim Biophys Acta 1853, 2492-2505, 2015.10.1016/j.bbamcr.2015.06.00626094770Search in Google Scholar

Pascual G, Avgustinova A, Mejetta S, Martin M, Castellanos A, Attolini CS, Berenguer A, Prats N, Toll A, Hueto JA, Bescos C, Di Croce L, Benitah SA. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541, 41-45, 2017.10.1038/nature2079127974793Search in Google Scholar

Phillips LM, Zhou X, Cogdell DE, Chua CY, Huisinga A, R Hess K, Fuller GN, Zhang W. Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies. J Pathol 239, 355-364, 2016.10.1002/path.4734491598027125842Search in Google Scholar

Pratheeshkumar P, Son YO, Divya SP, Wang L, Turcios L, Roy RV, Hitron JA, Kim D, Dai J, Asha P, Zhang Z, Shi X. Quercetin inhibits Cr(VI)-induced malignant cell transformation by targeting miR-21-PDCD4 signaling pathway. Oncotarget 2016.10.18632/oncotarget.10130558101728881718Search in Google Scholar

Praveen Kumar VR, Sehgal P, Th ota B, Patil S, Santosh V, Kondaiah P. Insulin like growth factor binding protein 4 promotes GBM progression and regulates key factors involved in EMT and invasion. J Neurooncol 116, 455-464, 2014.10.1007/s11060-013-1324-y24395346Search in Google Scholar

Ranke MB. Insulin-like growth factor binding-protein-3 (IGFBP-3). Best Pract Res Clin Endocrinol Metab 29, 701-711, 2015.10.1016/j.beem.2015.06.00326522455Search in Google Scholar

Ritz U, Nusselt T, Sewing A, Ziebart T, Kaufmann K, Baranowski A, Rommens PM, Hofmann A. Th e eff ect of different collagen modifi cations for titanium and titanium nitrite surfaces on functions of gingival fi broblasts. Clin Oral Investig 21, 255-265, 2016.10.1007/s00784-016-1784-526969500Search in Google Scholar

Rollerova E, Tulinska J, Liskova A, Kuricova M, Kovriznych J, Mlynarcikova A, Kiss A, Scsukova S. Titanium dioxide nanoparticles: some aspects of toxicity/focus on the development. Endocr Regul 49, 97-112, 2015.10.4149/endo_2015_02_9725960011Search in Google Scholar

Sabin MA, Russo VC, Azar WJ, Yau SW, Kiess W, Werther GA. IGFBP-2 at the interface of growth and metabolism - implications for childhood obesity. Pediatr Endocrinol Rev 8, 382-393, 2011.Search in Google Scholar

Simon M, Saez G, Muggiolu G, Lavenas M, Le Trequesser Q, Michelet C, Deves G, Barberet P, Chevet E, Dupuy D, Delville MH, Seznec H. In situ quantifi cation of diverse titanium dioxide nanoparticles unveils selective endoplasmic reticulum stress-dependent toxicity. Nanotoxicology 11, 134-145, 2017.10.1080/17435390.2017.127880328044465Search in Google Scholar

Sun X, Gao L, Chien HY, Li WC, Zhao J. Th e regulation and function of the NUAK family. J Mol Endocrinol 51, R15-R22, 2013.10.1530/JME-13-006323873311Search in Google Scholar

van Hove RP, Sierevelt IN, van Royen BJ, Nolte PA. Titanium-nitride coating of orthopaedic implants: a review of the literature. Biomed Res Int 2015, 485975, 2015.10.1155/2015/485975463705326583113Search in Google Scholar

Wang Y, Zhou XO, Zhang Y, Gao PJ, Zhu DL. Association of the CD36 gene with impaired glucose tolerance, impaired fasting glucose, type-2 diabetes, and lipid metabolism in essential hypertensive patients. Genet Mol Res 11, 2163-2170, 2012.10.4238/2012.July.10.222869067Search in Google Scholar

Wang J, Ding N, Li Y, Cheng H, Wang D, Yang Q, Deng Y, Yang Y, Li Y, Ruan X, Xie F, Zhao H, Fang X. Insulin-like growth factor binding protein 5 (IGFBP5) functions as a tumor suppressor in human melanoma cells. Oncotarget 6, 20636-20649, 2015.10.18632/oncotarget.4114465303126010068Search in Google Scholar

Yang J, Luo M, Tan Z, Dai M, Xie M, Lin J, Hua H, Ma Q, Zhao J, Liu A. Oral administration of nano-titanium dioxide particle disrupts hepatic metabolic functions in a mouse model. Environ Toxicol Pharmacol 49, 112-118, 2016.10.1016/j.etap.2016.12.00627984778Search in Google Scholar

Ze Y, Hu R, Wang X, Sang X, Ze X, Li B, Su J, Wang Y, Guan N, Zhao X, Gui S, Zhu L, Cheng Z, Cheng J, Sheng L, Sun Q, Wang L, Hong F. Neurotoxicity and gene-expressed profi le in brain-injured mice caused by exposure to titanium dioxide nanoparticles. J Biomed Mater Res A 102, 470-478, 2014.10.1002/jbm.a.3470523533084Search in Google Scholar

Zhu S, Xu F, Zhang J, Ruan W, Lai M. Insulin-like growth factor binding protein-related protein 1 and cancer. Clin Chim Acta 431, 23-32, 2014.10.1016/j.cca.2014.01.03724513543Search in Google Scholar